Triple Marker with Graph, 2nd Trimester near me in New Delhi
Understanding Triple Marker with Graph, 2nd Trimester in New Delhi
What is Triple Marker with Graph, 2nd Trimester in New Delhi?
The Triple Marker with Graph, 2nd Trimester test is a prenatal screening test typically conducted between 14-22 weeks of gestation, ideally between 15-20 weeks (the second trimester) of pregnancy, and tells about the risk of specific chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), neural tube defects (such as spina bifida) and anencephaly (a brain defect) in the fetus.
It measures the levels of three biomarkers in the mother’s blood: Alpha-fetoprotein (AFP), Human chorionic gonadotropin (HCG), and Estriol unconjugated (uE3). The levels of these markers, maternal age, gestational age, and ultrasound findings help determine the likelihood of these chromosomal conditions in the fetus. In addition to the traditional triple marker analysis, including a graphical representation enhances the interpretability of results.
No special preparation is required before undergoing the Triple Marker with Graph, 2nd Trimester test; you can eat or drink as per your daily routine. However, a pregnant woman must provide informed consent before undertaking this test. The laboratory personnel will explain the purpose, benefits, and limitations of this test.
What does Triple Marker with Graph, 2nd Trimester measure?
Contains 3 testsThe Triple Marker with Graph, 2nd Trimester test measures the levels of three specific markers in the blood of a pregnant woman. These markers are Alpha-Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG), and Estriol unconjugated (uE3).
The analysis of these three markers, along with other factors like maternal age and gestational age, helps assess the risk of Down syndrome, Edwards syndrome, and neural tube defects in the developing baby. The graph in the Triple Marker with Graph, 2nd Trimester test provides a visual representation of the levels of these markers during pregnancy.
It is noteworthy that the Triple Marker with Graph, 2nd Trimester test is a screening test, and any abnormal results may prompt further diagnostic testing for confirmation. Pregnant women should discuss their results and implications with their doctor.
HCG Beta Total Quantitative, Maternal
An HCG Beta Total Quantitative, Maternal test measures the levels of human chorionic gonadotropin (hCG) hormone in the blood. hCG is released in the blood during pregnancy and can be detected as early as 10 days after conception. The levels of this hormone gradually rise every 2 to 3 days (or 48 to 72 hours) and peak around 8 to 11 weeks after conception. After reaching the peak, the hCG levels decrease and remain steady for the rest of the pregnancy.
Know more about HCG Beta Total Quantitative, Maternal
Alpha Feto Protein, Maternal
An Alpha Feto Protein, Maternal test measures the amount of Alpha Fetoprotein in expectant mothers usually during the second trimester (14th and 22nd weeks). AFP is a protein produced by the fetus, primarily by the fetal liver and yolk sac, and it passes into the mother's blood. The test is typically performed to screen for certain fetal abnormalities, particularly neural tube defects (NTDs) such as spina bifida and anencephaly, as well as chromosomal abnormalities like Down syndrome (trisomy 21), Edwards syndrome (Trisomy 18), etc.
Detecting these abnormalities early in pregnancy allows for appropriate medical management and intervention.
Know more about Alpha Feto Protein, Maternal